Today: 9 April 2026
XRP price slips below $2 as tariff jitters and liquidations rattle crypto — what to watch next
20 January 2026
2 mins read

XRP price slips below $2 as tariff jitters and liquidations rattle crypto — what to watch next

New York, January 20, 2026, 17:16 (EST) — After-hours

  • XRP dropped roughly 5%, slipping under the $2 mark within the last 24 hours.
  • Equities took a hit as fresh U.S. tariff threats sparked a risk-off selloff that also spilled over into crypto.
  • Traders are eyeing if forced liquidations will slow down and if tariff news quiets ahead of Feb. 1.

XRP dropped roughly 5% on Tuesday, trading near $1.89 and hitting a low of $1.88 in the last 24 hours, per CoinMarketCap data. CoinMarketCap

Markets shifted sharply into risk-off territory after President Donald Trump threatened new tariffs targeting parts of Europe, triggering Wall Street’s largest single-day decline in three months and sending bitcoin tumbling over 3%, Reuters reported. Investors are bracing for a heavy U.S. data slate later this week, including GDP figures, January PMI readings, and the Personal Consumption Expenditures report—the Federal Reserve’s favored inflation metric. Reuters

The crypto pullback seemed more like a broad leverage unwind than a story about any single token. Total market cap dropped to roughly $3.23 trillion, while liquidations hit around $875 million in the past 24 hours, according to The Defiant citing Coinglass. These liquidations happen when leveraged positions are forcibly closed after losses exceed margin requirements. Matrixport analysts noted that traders were “neither chasing upside through options nor aggressively hedging downside risk.” The Defiant

XRP derivatives also faced pressure. Open interest—the total value of active futures contracts—was roughly $3.58 billion on Jan. 19, according to CryptoSlate, which cited CoinGlass. Liquidations hit about $42.44 million in the previous 24 hours. Funding rates, the small recurring fees that help anchor perpetual futures prices to spot, hovered near 0.0041%, the report added. CryptoSlate

Macro volatility is dominating for now. The Cboe Volatility Index hit its highest level in eight weeks as tariff fears rattled stocks, Treasuries, and the dollar, Reuters noted. “It’s a typical response to geopolitical turmoil: pull back on equity risk, buy gold, hold cash,” said Alex Morris, CEO and CIO of F/m Investments. Reuters

Buyers remain active on crypto dips, at least when it comes to bitcoin. Strategy reportedly purchased about $2.13 billion worth of bitcoin over the last eight days, even as the cryptocurrency slid 3.6% and its shares dropped 7.4%, according to Reuters. “Stopping would be as much a signal to the market as purchasing more,” said Nic Puckrin, analyst and co-founder of Coin Bureau. Reuters

Ripple, the firm most closely linked to XRP, hasn’t revealed any new catalyst to explain Tuesday’s price jump. Since the U.S. Securities and Exchange Commission dropped its case against Ripple Labs in August 2025, the token has faced fewer legal clouds. The company was hit with a $125 million fine and an injunction on certain institutional sales, Reuters reported. Reuters

But XRP stays a high-beta play when news breaks and leverage piles up. If the broader selloff worsens or margin calls pick up, altcoins could tumble sharply; however, if tariff talk eases, they might rebound just as swiftly.

Traders are on alert for any sign of a way out before Feb. 1, when Trump has threatened to slap an extra 10% tariff on imports from several European nations. That rate would jump to 25% on June 1 if talks over Greenland fall through. On Tuesday, Sweden’s Board of Trade warned that Swedish exports to the U.S. could plunge sharply if the tariffs go ahead. Reuters

The immediate question: will liquidations ease and volumes hold steady, or will another wave of risk-off selling push XRP even further from the $2 level traders are fixated on?

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Bitcoin price dips under $90,000 as tariff jitters rattle crypto — what to watch next
Previous Story

Bitcoin price dips under $90,000 as tariff jitters rattle crypto — what to watch next

Nvidia stock drops as China stalls H200 chip clearance, dragging AI chip names
Next Story

Nvidia stock drops as China stalls H200 chip clearance, dragging AI chip names

Go toTop